Brief Summary

Patients with post traumatic stress disorder (PTSD) will be randomized to a 12-week intervention of Sudarshan Kriya Yoga Trauma Relief Program (SKY) or a wait list control (WLC) to assess the effects of this intervention on symptoms of PTSD, depression, anxiety, quality of life, autonomic symptoms, and blood inflammatory markers.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2015

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 17, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2015

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

March 8, 2018

Status Verified

March 1, 2018

Enrollment Period

1.8 years

First QC Date

September 5, 2015

Last Update Submit

March 7, 2018

Conditions

Keywords

post traumatic stress disorder (PTSD)Sudarshan Kriya Yoga (SKY)

Outcome Measures

Primary Outcomes (1)

  • Reduction in PTSD symptoms as assessed by the clinician administered PCL-5 (Post Traumatic Stress Disorder Check List).

    The clinician administered PCL-5 (Post Traumatic Stress Disorder Check List). willl be used to assess a change in PTSD symptoms from baseline to weeks 4, 8, 12, and 24.

    Change from baseline to: 4 weeks, 8 weeks, 12 weeks, and 24 weeks

Secondary Outcomes (8)

  • Reduction in depression symptoms as assessed by the clinician administered HAM-D 17 (Hamilton Depression Score).

    Change from baseline to: 4 weeks, 8 weeks, 12 weeks, and 24 weeks

  • Reduction in anxiety symptoms as assessed by the HAM-A (Hamilton Anxiety Scale).

    Change from baseline to: 4 weeks, 8 weeks, 12 weeks, and 24 weeks

  • Improvement in autonomic parameters including heart rate variability and heart rate as assessed by a Bluetooth enabled Polar H7 Heart Rate Sensor.

    Change from baseline to: 12 weeks, and 24 weeks.

  • Improvement in blood inflammatory markers as measured by enzyme-linked immunosorbent assay.

    Change from baseline to: 12 weeks, and 24 weeks.

  • Reduction in depression symptoms using self-rated BDI 21 (Beck's Depression Inventory).

    Change from baseline to: 4 weeks, 8 weeks, 12 weeks, and 24 weeks

  • +3 more secondary outcomes

Study Arms (2)

Sudarshan Kriya Yoga Trauma Relief Program (SKY)

EXPERIMENTAL

Participants will receive training in SKY soon after completing baseline assessments.

Other: Sudarshan Kriya Yoga Trauma Relief Program (SKY)

wait list control (WLC)

NO INTERVENTION

Participants will receive training in SKY after 12 weeks have passed since the baseline assessment.

Interventions

Participants in the SKY group will undergo a 12-week training course in Sudarshan Kriya Yoga (SKY) conducted by certified instructors from the Art of Living Foundation.

Sudarshan Kriya Yoga Trauma Relief Program (SKY)

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have an Axis 1 diagnosis of PTSD as per CAPS5 (Clinician Administered PTSD Scale for DSM 5- past month version) criteria.
  • If participants are using antidepressants, they must be at therapeutic doses for a minimum of four weeks prior to commencing the study. Patients who are not willing to take any medications will also be eligible for the study
  • Sufficient hearing to be able to follow verbal instructions and able to sit without physical discomfort for 60 minutes.
  • Willing and able to attend 6 initial SKY training sessions and 75% of follow up sessions
  • Not pregnant and willing to remain not pregnant for the duration of the study

You may not qualify if:

  • They are currently participating in other similar studies.
  • If the patient scores severe or extreme on Depersonalization (item 29) or Derealization (item 30) items of CAPS5.
  • Other significant mental health diagnosis including substance dependence, Neurocognitive disorder, Obsessive Compulsive Disorder, Panic Disorder, Bipolar disorder and/or Personality disorder (confirmed by Psychiatrist and MINI)
  • High risk of suicide as elicited by clinical interview (MINI).
  • Psychotic episodes within the past 12 months.
  • Traumatic Brain Injury (TBI) as defined by loss of consciousness for more than 20 minutes and/or Glasgow Coma Scale score less than or equal to 12. (The researcher will use self-reported histories to screen for traumatic brain injury and if necessary confirmed by medical records.
  • Currently practicing any type of formal meditation, mindfulness or breathing techniques regularly.
  • Serious cardiovascular disease in the past 12 months (i.e. myocardial infarction, stroke, TIA, uncontrolled hypertension), or a past history of neurological disease (including Parkinson's Disease), seizures, or diabetic neuropathy
  • Major surgery within 6 weeks prior to commencement of the intervention, or a scheduled major surgery during the intervention period. (This is due to the physical rigor of the breathing techniques).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Victoria Hospital, LHSC

London, Ontario, N6A 5W9, Canada

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

September 5, 2015

First Posted

September 17, 2015

Study Start

November 1, 2015

Primary Completion

September 1, 2017

Study Completion

September 1, 2017

Last Updated

March 8, 2018

Record last verified: 2018-03

Locations